Fabrizio, M., Singhal, M., Emond, B., Rossi, C., Bungay, R., Liu, S., Pilon, D., Khaki, A. R. (2026). Front-line (1L) treatment and recurrence patterns among patients with high-risk non–muscle-invasive bladder cancer (HR-NMIBC) with papillary carcinoma (PAP) or carcinoma in situ (CIS) following bacillus Calmette-Guérin (BCG) or other intravesical therapies (IVT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.708